Dr. Jacqueline Shan

Founder, President and CEO at PBG BioPharma Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Edmonton, Alberta, Canada, CA
Languages
  • English -
  • Chinese -

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Canada
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Founder, President and CEO
      • Apr 2018 - Present

      PBG PBG BioPharma (Phytochemical-Biopharmaceutical-Group) , a vertically integrated company focusing on the research, development and manufacturing of biopharmaceuticals and nutraceuticals. Using its proprietary GenBioChem® triple fingerprinting technology platform, PBG takes a pharmaceutical approach to develop and manufacturing phytochemical-based biopharmaceutical and nutraceutical ingredients including cannabinoids. PBG owns multiple manufacturing, laboratory facilities and a pharmacy in Alberta, BC and Toronto including total 70,000 square foot state-of -the -art, FDA and Health Canada approved, GMP standard pharmaceutical and nutraceutical manufacturing facilities and a suit of ISO 10725 certified labs. PBG employs a team of biopharmaceutical and pharmacy professionals with decades of experience and successful track records. PBG offers business solutions through contract manufacturing, analytical, product development services and phytochemical ingredients including cannabinoids and psilocybin. PBG also serves nutraceutical market with GenBioChem®Immunity, Memory and Energy. https://pbgbiopharma.com/ BioPharma

    • Canada
    • Alternative Medicine
    • Founder
      • May 2017 - Present

      Natural Rf is a Canadian life science company focusing on development of natural health consumer products. The company launched Allergy-RF , a clinically proven natural health product for relieving year-round, seasonal and Enviromental allergies.

    • Founder
      • May 2016 - Present

    • Chief Strategist
      • Apr 2015 - Apr 2018

      Madenco is focused on bringing products to the consumer health and pharmaceutical markets utilizing our proprietary transdermal delivery and Nanoparticle formulation technologies. We recently launched Bellus Skin Rejuvenation Serum, the world's 1st skin permeable fusion protein targeting both EGF and FGF1 receptors. Check the SP skin super permeable technology and the amazing Bellus Rejuvenation Serum at www.bellusskin.com Madenco is focused on bringing products to the consumer health and pharmaceutical markets utilizing our proprietary transdermal delivery and Nanoparticle formulation technologies. We recently launched Bellus Skin Rejuvenation Serum, the world's 1st skin permeable fusion protein targeting both EGF and FGF1 receptors. Check the SP skin super permeable technology and the amazing Bellus Rejuvenation Serum at www.bellusskin.com

    • Founder
      • May 2013 - Dec 2016

      Afinity Life Sciences Inc. was an Canadian Life sciences company focused on natural health products Afinity Life Sciences Inc. was an Canadian Life sciences company focused on natural health products

    • Alternative Medicine
    • 1 - 100 Employee
    • Co-founder, President and CEO, Chief Scientific Officer
      • Feb 1992 - Dec 2011

      Co-founded the company; Developed proprietary technology. Led product development and commercialization. Developed and commercialized COLD-FX, the #1 COLDs and Flu brand in Canada Co-founded the company; Developed proprietary technology. Led product development and commercialization. Developed and commercialized COLD-FX, the #1 COLDs and Flu brand in Canada

Education

  • University of Alberta
    -
  • Chinese Academy of Medical Sciences
    Ph.D, D.Sc., Physiology, Pharmacology
    -
  • Peking Union Medical College
    Doctor of Philosophy - PhD, Pharmacology
    -
  • University of Alberta
    Doctor of Philosophy - PhD, Molecular Physiology
    -

Community

You need to have a working account to view this content. Click here to join now